🔎 Trials Near Me

Akèy › Amiloidoz ereditè ki gen rapò ak transthyretin › Connecticut › New Haven

Etid klinik pou Amiloidoz ereditè ki gen rapò ak transthyretin nan New Haven, CT

3 etid pou Amiloidoz ereditè ki gen rapò ak transthyretin ap chèche patisipan nan sit nan ak bò kote New Haven (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

Ap rekriteEtid obsèvasyon
  • Research Site, New Haven
Laj 18 a 130 · Tout sèks · Mizajou Sep 23, 2026 · NCT06465810

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

Ap rekriteFaz 3
  • Yale University School of Medicine - Section of Cardiology, New Haven
Laj 18 a 75 · Tout sèks · Mizajou Aug 4, 2026 · NCT06563895

MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

Ap rekriteFaz 3
  • Yale University School of Medicine, New Haven
Laj 18 a 90 · Tout sèks · Mizajou Mar 27, 2026 · NCT06128629

Etid Amiloidoz ereditè ki gen rapò ak transthyretin nan lòt vil

Lòt etid nan New Haven

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.